BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21676435)

  • 1. Association between natural killer cells and regression in melanocytic lesions.
    McKay K; Moore PC; Smoller BR; Hiatt KM
    Hum Pathol; 2011 Dec; 42(12):1960-4. PubMed ID: 21676435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.
    Speeckaert R; van Geel N; Luiten RM; van Gele M; Speeckaert M; Lambert J; Vermaelen K; Tjin EP; Brochez L
    Anticancer Res; 2011 Nov; 31(11):3697-703. PubMed ID: 22110189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
    Wenzel J; Bekisch B; Uerlich M; Haller O; Bieber T; Tüting T
    Am J Clin Pathol; 2005 Jul; 124(1):37-48. PubMed ID: 15923172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
    Lyle S; Salhany KE; Elder DE
    Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
    J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
    Kornstein MJ; Brooks JS; Elder DE
    Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the immunophenotype of the inflammatory cells in melanomas with regression and halo nevi.
    Botella-Estrada R; Kutzner H
    Am J Dermatopathol; 2015 May; 37(5):376-80. PubMed ID: 25222195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression of natural killer cell lymphoma.
    Isobe Y; Aritaka N; Sasaki M; Oshimi K; Sugimoto K
    J Clin Pathol; 2009 Jul; 62(7):647-50. PubMed ID: 19561234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.
    Halliday GM; Patel A; Hunt MJ; Tefany FJ; Barnetson RS
    World J Surg; 1995; 19(3):352-8. PubMed ID: 7638987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight.
    Hussein MR
    Br J Dermatol; 2005 Jul; 153(1):18-21. PubMed ID: 16029321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic cutaneous lesions and melanotic regional lymph nodes in slaughter swine.
    Bundza A; Feltmate TE
    Can J Vet Res; 1990 Apr; 54(2):301-4. PubMed ID: 2357671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regressing malignant melanoma.
    Grafton WD
    J La State Med Soc; 1994 Dec; 146(12):535-9. PubMed ID: 7844465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.